Primary CNS Lymphoma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma
Condition: Primary Central Nervous System Lymphoma Interventions: Drug: Glucarpidase; Drug: Methotrexate (MTX) Sponsors: Assistance Publique - Hôpitaux de Paris; BTG International Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 26, 2021 Category: Research Source Type: clinical trials
